Share This

Related Topics News -

     
 Title only   |   Print 
     
石藥集團藥物JMT202獲批在中國開展臨床試驗

2024-05-17T  
石藥集團旗下流感藥物通過國家藥監局一致性評價

2024-05-14T  
《大行》大摩升石藥集團目標價至12元 評級「增持」

2024-05-09T  
石藥受託人根據股份獎勵計劃購479萬股

2024-04-26T  
石藥高選擇性MAT2A抑制劑美國臨床試驗申請獲批

2024-04-26T  
副總理劉國中赴上海調研 稱推動醫學科技創新

2024-04-25T  

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.